Altium Capital Management LP lifted its holdings in shares of Amylyx Pharmaceuticals, Inc. (NASDAQ:AMLX – Free Report) by 32.1% during the first quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The firm owned 185,000 shares of the company’s stock after purchasing an additional 45,000 […]
Altium Capital Management LP acquired a new position in Vera Therapeutics, Inc. (NASDAQ:VERA – Free Report) in the first quarter, according to its most recent filing with the Securities and Exchange Commission. The institutional investor acquired 286,000 shares of the company’s stock, valued at approximately $2,219,000. Altium Capital Management LP owned approximately 0.65% of Vera […]
Altium Capital Management LP purchased a new stake in shares of Inspire Medical Systems, Inc. (NYSE:INSP – Free Report) during the first quarter, HoldingsChannel.com reports. The institutional investor purchased 12,500 shares of the company’s stock, valued at approximately $2,926,000. Inspire Medical Systems makes up about 1.6% of Altium Capital Management LP’s investment portfolio, making the […]
Altium Capital Management LP, a New York-based investment firm, recently made a significant move in the stock market by acquiring a new stake in Alimera Sciences Inc. This article provides an in-depth analysis of the transaction, the profiles of both entities, and the potential implications of this strategic move. On August 15, 2023, Altium Capital Management LP purchased 2,984,803 shares of Alimera Sciences Inc at a price of $3.57 per share. This acquisition had a 7.46% impact on the firm's portfolio, making it a significant transaction.
Evogene Ltd. (NASDAQ:EVGN) Q2 2023 Earnings Call Transcript August 18, 2023 Operator: Ladies and gentlemen, thank you for standing by. Welcome to Evogene’s Second Quarter 2023 Results Conference Call. [Operator Instructions] As a reminder, this conference is being recorded on August 17, 2023. Before we begin, I would like to caution that certain statements made […]